台湾南部监狱丙型肝炎患者治疗效果：真实世界回顾性分析

数据集获取（Figshare）

• 源站标题：Treatment Effectiveness of Patients with Hepatitis C in the Prisons of Southern Taiwan: A Real-life Retrospective Analysis
• DOI：10.6084/m9.figshare.22677895.v1
• 发布日期：2023-04-21
• 文件数：3 个
• 文件总体积：139.66 KB
• 源站页面：https://figshare.com/articles/dataset/Treatment_Effectiveness_of_Patients_with_Hepatitis_C_in_the_Prisons_of_Southern_Taiwan_A_Real-life_Retrospective_Analysis/22677895

命令行下载

curl -L -o "Final statics - BMJ.xlsx" "https://ndownloader.figshare.com/files/40248016"
curl -L -o "Final statics - BMJ.txt" "https://ndownloader.figshare.com/files/40248025"
curl -L -o "README.rtf" "https://ndownloader.figshare.com/files/40248040"

文件清单

• Final statics - BMJ.xlsx（87.63 KB）
• Final statics - BMJ.txt（50.22 KB）
• README.rtf（1.81 KB）

文件总体积 139.66 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objective

Hepatitis C is an important risk factor for cirrhosis and liver cancer in the Taiwanese population. Domestic prisons reported a higher rate of hepatitis C infection than the national average. Efficient and effective treatment of patients with hepatitis C in prisons is required to decrease the number of infections. This study analyzed the effectiveness of hepatitis C treatment in prison patients.

Design

This retrospective analysis included adult patients with hepatitis C who received direct-acting antiviral agents between 2018 and 2021. 

Setting

The special hepatitis C clinics in the two prisons were run by a medium-sized hepatitis C treatment hospital in Southern Taiwan. Three direct-acting antiviral agents, sofosbuvir/ledipasvir for 12 weeks, glecaprevir/pibrentasvir for 8 or 12 weeks, and sofosbuvir/velpatasvir for 12 weeks, were adopted based on patient characteristics.

Participants

470 patients were included. 

Outcome measure

The sustained virological response at 12 weeks after the end of treatment was compared between the different groups.

Results

Most of the patients were men (70.0%) with a median age of 44 years. The most prevalent hepatitis C virus genotype was genotype 1 (44.26%). A total of 240 patients (51.06%) had a history of injectable drug use; 44 (9.36%) and 71 (15.11%) patients were co-infected with hepatitis B virus and human immunodeficiency virus, respectively. Only 51 patients (10.85%) had liver cirrhosis. Most patients (98.30%) had normal renal function or no history of kidney disease. The patients had a sustained virological response achievement rate of 99.2%. 

Conclusion

Direct-acting antiviral agents are effective for treating hepatitis C in Taiwanese prisoners.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.22677895.v1（source: https://figshare.com/articles/dataset/Treatment_Effectiveness_of_Patients_with_Hepatitis_C_in_the_Prisons_of_Southern_Taiwan_A_Real-life_Retrospective_Analysis/22677895）。